High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma - Concepedia

Concepedia

Publication | Open Access

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

DOI Full Paper Access

73

Citations

24

References

2023

Year

Hannah Yang, Beodeul Kang, Yeonjung Ha, Sung Hwan Lee, Il Hwan Kim, Hyeyeong Kim, Won Suk Lee, Gwangil Kim, Sanghoon Jung, Sun Young Rha,

Reduced Clinical BenefitHepatologyUnresectable Hepatocellular CarcinomaMedicineImmunologyImmune Checkpoint InhibitorLiver CancerOncologyRadiation OncologyHigh Serum Il-6Hepatocellular Carcinoma

References

	Year	Citations

Page 1

Page 1